These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35305724)

  • 1. Antivenom: An immunotherapy for the treatment of snakebite envenoming in sub-Saharan Africa.
    Mender MM; Bolton F; Berry C; Young M
    Adv Protein Chem Struct Biol; 2022; 129():435-477. PubMed ID: 35305724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of the Proteomic Profiling of African Viperidae and Elapidae Snake Venoms and Their Antivenom Neutralisation.
    Offor BC; Muller B; Piater LA
    Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa.
    Calvete JJ; Cid P; Sanz L; Segura A; Villalta M; Herrera M; León G; Harrison R; Durfa N; Nasidi A; Theakston RD; Warrell DA; Gutiérrez JM
    Am J Trop Med Hyg; 2010 Jun; 82(6):1194-201. PubMed ID: 20519622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom.
    Casewell NR; Cook DA; Wagstaff SC; Nasidi A; Durfa N; Wüster W; Harrison RA
    PLoS Negl Trop Dis; 2010 Oct; 4(10):e851. PubMed ID: 21049058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa.
    Segura A; Villalta M; Herrera M; León G; Harrison R; Durfa N; Nasidi A; Calvete JJ; Theakston RD; Warrell DA; Gutiérrez JM
    Toxicon; 2010; 55(2-3):369-74. PubMed ID: 19699756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the intrageneric neutralization scope of monospecific, bispecific/monogeneric and polyspecific/monogeneric antisera raised in horses immunized with sub-Saharan African snake venoms.
    Sánchez A; Durán G; Segura Á; Herrera M; Vargas M; Villalta M; Arguedas M; Moscoso E; Umaña D; Gómez A; Gutiérrez JM; León G
    PLoS Negl Trop Dis; 2024 May; 18(5):e0012187. PubMed ID: 38809847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venom-Induced Consumption Coagulopathy Unresponsive to Antivenom After Echis carinatus sochureki Envenoming.
    Gopalakrishnan M; Yadav P; Mathur R; Midha N; Garg MK
    Wilderness Environ Med; 2021 Jun; 32(2):221-225. PubMed ID: 33781663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
    Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antivenom therapy of carpet viper (Echis ocellatus) envenoming: effectiveness and strategies for delivery in West Africa.
    Habib AG; Warrell DA
    Toxicon; 2013 Jul; 69():82-9. PubMed ID: 23339853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-Aided Analysis of West Sub-Saharan Africa Snakes Venom towards the Design of Epitope-Based Poly-Specific Antivenoms.
    Ros-Lucas A; Bigey P; Chippaux JP; Gascón J; Alonso-Padilla J
    Toxins (Basel); 2022 Jun; 14(6):. PubMed ID: 35737079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The medical threat of mamba envenoming in sub-Saharan Africa revealed by genus-wide analysis of venom composition, toxicity and antivenomics profiling of available antivenoms.
    Ainsworth S; Petras D; Engmark M; Süssmuth RD; Whiteley G; Albulescu LO; Kazandjian TD; Wagstaff SC; Rowley P; Wüster W; Dorrestein PC; Arias AS; Gutiérrez JM; Harrison RA; Casewell NR; Calvete JJ
    J Proteomics; 2018 Feb; 172():173-189. PubMed ID: 28843532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?
    Laustsen AH; Johansen KH; Engmark M; Andersen MR
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005361. PubMed ID: 28158193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Which antivenom for Cerastes envenoming?].
    Mion G; Larréché S
    Med Sante Trop; 2014; 24(1):105-6. PubMed ID: 24736220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom.
    Meyer WP; Habib AG; Onayade AA; Yakubu A; Smith DC; Nasidi A; Daudu IJ; Warrell DA; Theakston RD
    Am J Trop Med Hyg; 1997 Mar; 56(3):291-300. PubMed ID: 9129531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrageneric cross-reactivity of monospecific rabbit antisera against venoms of the medically most important Bitis spp. and Echis spp. African snakes.
    Gómez A; Sánchez A; Durán G; Cordero D; Segura Á; Vargas M; Solano D; Herrera M; Chaves-Araya S; Villalta M; Sánchez M; Arguedas M; Díaz C; Gutiérrez JM; León G
    PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010643. PubMed ID: 35960772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective observational phase IV study on effectiveness of animal derived polyclonal antibody antivenoms against West African carpet viper (Echis romani) induced coagulopathy and mortality.
    Dajel TB; Abubakar SB; Dan-Amarya NM; Azi NA; Mu'azu S; Hamza M; Iliyasu G; Gwarzo MY; Habib AG
    Toxicon; 2023 Aug; 232():107211. PubMed ID: 37393958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of three polyspecific antivenoms against the venom of Echis ocellatus: Neutralization of toxic activities and antivenomics.
    Calvete JJ; Arias AS; Rodríguez Y; Quesada-Bernat S; Sánchez LV; Chippaux JP; Pla D; Gutiérrez JM
    Toxicon; 2016 Sep; 119():280-8. PubMed ID: 27377229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa.
    Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA
    J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing the Cross-Neutralisation Potential of Existing Antivenoms for Mitigating the Outcomes of Snakebite in Sub-Saharan Africa.
    Khochare S; Jaglan A; Rashmi U; Dam P; Sunagar K
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management.
    Ainsworth S; Menzies SK; Casewell NR; Harrison RA
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008579. PubMed ID: 32817682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.